David Mathieu

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text

RADIOSURGERY AS DEFINITIVE MANAGEMENT OF INTRACRANIAL MENINGIOMAS

Douglas Kondziolka, David Mathieu, L. Dade Lunsford et al. · Neurosurgery · 2008 · 436 citations

Neuro-oncology, Skull Base, Radiation Therapy +11

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 356 citations · Full text

Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study

Jason P. Sheehan, Robert M. Starke, David Mathieu et al. · Journal of neurosurgery · 2013 · 219 citations